Edward White

Q: What is Edward White's success rate?

Edward White currently has a success rate of 100.

Q: What is the average return of Edward White's calls?

Their stock ratings have generated an average return of 354.1841716816169.

HC Wainwright & Co. | Healthcare

Edward White is an analyst from HC Wainwright & Co. specializing in the Healthcare sector. They are beginning to establish their track record, with 1 stock rating so far. Their current stats show a success rate of 100.00% and an average return of 354.18%.

Edward White has only issued 1 rating so far. While the sample size is small, their early calls show a success rate of 100.00% and an average return of 354.18%. Investors may find their initial activity in the Healthcare sector worth watching as they build a track record.

Out of 4771

Total Ratings

+100.00%

Success Rate

+354.18%

Average Return

Recent Ratings Analysis

INZY

Buy

Apr 10, 2025

Target

$16.00

Current

$4.00

Performance

354.18%

Edward White rated INZY as Buy on Apr 10, 2025, setting a price target of 16. The call has proven timely, with shares rising 354.18% toward the price target of 16.

VALN

Buy

Apr 09, 2025

Target

$17.00

Current

$6.69

Performance

-1.18%

On Apr 09, 2025, VALN was given a Buy rating by Edward White, with a target price of 17. The stock traded sideways with a -1.18% move, keeping the bullish thesis unresolved.

NYXH

Buy

Apr 08, 2025

Target

$15.00

Current

$1.50

Performance

-75.25%

NYXH received a Buy rating from Edward White on Apr 08, 2025, aiming for 15. The rating hasn’t played out as hoped, with the stock trading 75.25% below expectations.

SABS

Buy

Apr 01, 2025

Target

$6.00

Current

$3.42

Performance

178.05%

On Apr 01, 2025, Edward White published a Buy outlook on SABS, with a target of 6. Shares gained 178.05%, underscoring the accuracy of the bullish outlook toward 6.

CRIS

Buy

Mar 31, 2025

Target

$16.00

Current

$1.16

Performance

-97.24%

Edward White on Mar 31, 2025 assigned CRIS a Buy rating, with a price target of 16. The call has struggled to gain traction, with shares losing 97.24%.

IKT

Hold

Mar 28, 2025

Target

—

Current

$2.33

Performance

1.75%

On Mar 28, 2025, Edward White reaffirmed IKT with a Neutral rating, targeting null. The neutral call matched muted market action of 1.75%.

SNSE

Buy

Mar 28, 2025

Target

$4.00

Current

$13.85

Performance

36.24%

SNSE was rated Buy by Edward White on Mar 28, 2025, with a price objective of 4. A bullish response from the market helped close the gap of -9.85 to the target.

SXTP

Hold

Mar 28, 2025

Target

—

Current

$0.93

Performance

-87.36%

On Mar 28, 2025, Edward White initiated coverage on SXTP with a Neutral rating and target of null. The rating matched the stock’s inability to hold above 0.93.

ARTV

Buy

Mar 26, 2025

Target

$20.00

Current

$10.42

Performance

186.26%

Edward White issued a Buy recommendation for ARTV on Mar 26, 2025, price target set at 20. Investors following the Buy call captured upside momentum, with shares now at 10.42.

AURA

Buy

Mar 25, 2025

Target

$25.00

Current

$6.99

Performance

-1.27%

On Mar 25, 2025, AURA was evaluated by Edward White, who gave a Buy rating and target of 25. So far, the Buy call awaits clearer momentum, with shares flat at 6.99.

BOLT

Hold

Mar 25, 2025

Target

—

Current

$3.73

Performance

788.10%

Edward White rated BOLT as Neutral on Mar 25, 2025, setting a price target of null. Despite the Hold call, shares climbed 788.10% to 3.73, revealing unexpected momentum.

LRMR

Buy

Mar 25, 2025

Target

$16.00

Current

$3.85

Performance

66.67%

On Mar 25, 2025, LRMR was given a Buy rating by Edward White, with a target price of 16. The stock rallied 66.67% after the rating, narrowing the gap to the target of 16 and validating the bullish stance.

IFRX

Buy

Mar 21, 2025

Target

$8.00

Current

$2.05

Performance

60.16%

IFRX received a Buy rating from Edward White on Mar 21, 2025, aiming for 8. Momentum has favored the Buy call, with shares climbing from 2.05 to 2.05, rewarding those who trusted the recommendation.

AVTX

Hold

Mar 20, 2025

Target

—

Current

$17.18

Performance

112.89%

On Mar 20, 2025, Edward White published a Neutral outlook on AVTX, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

ACET

Hold

Mar 07, 2025

Target

—

Current

$9.53

Performance

1097.09%

Edward White on Mar 07, 2025 assigned ACET a Neutral rating, with a price target of null. Shares outperformed expectations, climbing 1097.09% despite the neutral view.

CMRX

Hold

Mar 05, 2025

Target

$11.00

Current

$8.54

Performance

0.95%

On Mar 05, 2025, Edward White reaffirmed CMRX with a Neutral rating, targeting 11. The neutral call matched muted market action of 0.95%.

TGTX

Buy

Mar 04, 2025

Target

$55.00

Current

$55.39

Performance

55.50%

TGTX was rated Buy by Edward White on Mar 04, 2025, with a price objective of 55. A bullish response from the market helped close the gap of -0.39 to the target.

SNDX

Buy

Mar 04, 2025

Target

$51.00

Current

$18.82

Performance

30.88%

On Mar 04, 2025, Edward White initiated coverage on SNDX with a Buy rating and target of 51. The stock’s climb of 30.88% since the call highlights the foresight in the rating.

PBYI

Buy

Feb 28, 2025

Target

$7.00

Current

$9.17

Performance

156.15%

Edward White issued a Buy recommendation for PBYI on Feb 28, 2025, price target set at 7. Investors following the Buy call captured upside momentum, with shares now at 9.17.

CGEM

Buy

Feb 28, 2025

Target

$33.00

Current

$21.00

Performance

147.35%

On Feb 28, 2025, CGEM was evaluated by Edward White, who gave a Buy rating and target of 33. This case illustrates how a timely bullish rating can translate into tangible gains of 147.35%.

KPTI

Buy

Feb 26, 2025

Target

$56.00

Current

$1.62

Performance

-83.52%

Edward White rated KPTI as Buy on Feb 26, 2025, setting a price target of 56. The stock has underperformed, dropping 83.52% despite the bullish target of 56.

DVAX

Buy

Feb 21, 2025

Target

$31.00

Current

$15.50

Performance

16.28%

On Feb 21, 2025, DVAX was given a Buy rating by Edward White, with a target price of 31. The stock rallied 16.28% after the rating, narrowing the gap to the target of 31 and validating the bullish stance.

LUMO

Hold

Oct 24, 2024

Target

$4.25

Current

$4.34

Performance

-0.23%

LUMO received a Neutral rating from Edward White on Oct 24, 2024, aiming for 4.25. Shares remained flat at 4.34, aligning with the neutral rating.

TCON

Hold

Jul 01, 2024

Target

—

Current

$0.03

Performance

-97.10%

On Jul 01, 2024, Edward White published a Neutral outlook on TCON, with a target of null. Weakness in the stock, now at 0.0322, supported the conservative rating.

GTHX

Buy

Jun 25, 2024

Target

$3.00

Current

$7.16

Performance

225.45%

Edward White on Jun 25, 2024 assigned GTHX a Buy rating, with a price target of 3. The Buy call aligned well with market performance, producing a gain of 225.45%.

GLYC

Hold

Jun 04, 2024

Target

—

Current

$15.71

Performance

-46.56%

On Jun 04, 2024, Edward White reaffirmed GLYC with a Neutral rating, targeting null. The Hold stance reflected market caution that was later justified.

Frequency Asked Questions

Who is Edward White?

Edward White is an analyst from HC Wainwright & Co. specializing in the Healthcare sector.

What is Edward White's success rate?

Edward White currently has a success rate of +100.00%.

How many ratings has Edward White issued?

Edward White has issued 1 stock ratings so far.

What is the average return of Edward White's calls?

Their stock ratings have generated an average return of +354.18%.

What is Edward White's ranking?

Edward White is ranked #5 out of 4771 analysts.

What types of ratings does Edward White give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Edward White?

You can follow Edward White by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Edward White?

Their latest rating was a Buy on INZY issued on 2025-04-10.